Identification of a Sequence Element from p53 That Signals for Mdm2-Targeted Degradation

REFERENCES

• Ashcroft, M., Kubbutat, M. H., and Vousden, K. H.. 1999. Regulation of p53 function and stability by phosphorylation. Mol. Cell. Biol. 19:1751–1758
   PubMed Web of Science ®Google Scholar
• Barak, Y. M., Juven, T., Haffner, R., and Oren, M.. 1993. Mdm2 expression is induced by wild type p53 activity. EMBO J. 12:461–468
   PubMed Web of Science ®Google Scholar
• Blattner, C., Tobiasch, E., Litfen, M., Rahmsdorf, H. J., and Herrlich, P.. 1999. DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation. Oncogene 18:1723–1732
   PubMed Web of Science ®Google Scholar
• Chen, J. V., Marechal, and Levine, A. J.. 1993. Mapping of the p53 and mdm2 interaction domains. Mol. Cell. Biol. 13:4107–4114
   PubMed Web of Science ®Google Scholar
• Chen, J., Wu, X., Lin, J., and Levine, A. J.. 1996. Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16:2445–2452
   PubMed Web of Science ®Google Scholar
• Chen, J., Lin, J., and Levine, A. J.. 1995. Regulation of transcription function of the p53 tumor suppressor by the mdm-2 oncogene. Mol. Med. 1:142–152
   PubMedGoogle Scholar
• Chen, X., Ko, L. J., Jayaraman, L., and Prives, C.. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10:2438–2451
   PubMed Web of Science ®Google Scholar
• Davison, T. S., Vagner, C., Kaghad, M., Ayed, A., Caput, D., and Arrowsmith, C. H.. 1999. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J. Biol. Chem. 274:18709–18714
   PubMed Web of Science ®Google Scholar
• Dobbelstein, M., Wienzek, S., Konig, C., and Roth, J.. 1999. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein. Oncogene 18:2101–2106
   PubMed Web of Science ®Google Scholar
• Fu, L., and Benchimol, S.. 1997. Participation of the human p53 3′ UTR translational repression and activation following gamma-irradiation. EMBO J. 16:4117–4125
   PubMed Web of Science ®Google Scholar
• Gottleib, T. M., and Oren, M.. 1995. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287:77–102
   Google Scholar
• Haupt, Y., Maya, R., Kazaz, A., and Oren, M.. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296–299
   PubMed Web of Science ®Google Scholar
• Honda, R., Tanaka, H., and Yasuda, H.. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25–27
   PubMed Web of Science ®Google Scholar
• Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P.. 1993. Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Res. 21:3167–3174
   PubMed Web of Science ®Google Scholar
• Hupp, T. R., Sparks, A., and Lane, D. P.. 1995. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83:237–245
   PubMed Web of Science ®Google Scholar
• Jones, S. N., Roe, A. E., Donehower, L. A., and Bradley, A.. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378:206–208
   PubMed Web of Science ®Google Scholar
• Jost, C., Martin, M., and Kaelin, W. G.. 1997. P73 is a human p53-related protein that can induce apoptosis. Nature 389:191–194
   PubMed Web of Science ®Google Scholar
• Kaghad, M. H., Bonnet, Yang, A., Creancier, L., Biscan, J. C., Valent, A., Minty, A., Chalon, P., Llias, J.-M., Damont, X., Ferrara, P., McKeon, F., and Caput, D.. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809–819
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W.. 1991. Participation of p53 in the cellular response to DNA damage. Cancer Res. 51:6304–6311
   PubMed Web of Science ®Google Scholar
• Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinzler, K. W., and Vogelstein, B.. 1992. Oncogenetic forms of p53 inhibit p53-regulated gene expression. Science 256:827–829
   PubMed Web of Science ®Google Scholar
• Ko, L. J., and Prives, C.. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054–1072
   PubMed Web of Science ®Google Scholar
• Kubbutat, M. H., Jones, S. N., and Vousden, K. H.. 1997. Regulation of p53 stability by Mdm2. Nature 387:299–303
   PubMed Web of Science ®Google Scholar
• Kubbutat, M. H. G., Ludwig, R. L., Ashcroft, M., and Vousden, K. H.. 1998. Regulation of Mdm2-directed degradation by the C terminus of p53. Mol. Cell. Biol. 18:5690–5698
   PubMed Web of Science ®Google Scholar
• Levine, A. J.. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323–331
   PubMed Web of Science ®Google Scholar
• Maki, C. G., and Howley, P. M.. 1997. Ubiquitination of p53 and p21 is differentially affected by ionizing radiation and UV radiation. Mol. Cell. Biol. 17:355–363
   PubMed Web of Science ®Google Scholar
• Maki, C. G., Huibregtse, J. M., and Howley, P. M.. 1996. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res. 56:2649–2654
   PubMed Web of Science ®Google Scholar
• Maltzman, W., and Czyzyk, L.. 1984. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4:1689–1694
   PubMed Web of Science ®Google Scholar
• Midgley, C. A., and Lane, D. P.. 1997. p53 protein stability in tumor cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15:1179–1189
   PubMed Web of Science ®Google Scholar
• Momand, J., Zambetti, G. P., Olson, D. C., Geoge, D. L., and Levine, A. J.. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237–1245
   PubMed Web of Science ®Google Scholar
• Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F., and Deppert, W.. 1995. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14:4442–4449
   PubMed Web of Science ®Google Scholar
• Nelson, W. G., and Kastan, M.. 1994. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1815–1823
   PubMed Web of Science ®Google Scholar
• Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., and Vogelstein, B.. 1993. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 362:857–860
   PubMed Web of Science ®Google Scholar
• Price, B. D., and Calderwood, S. K.. 1993. Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene 8:3055–3062
   PubMedGoogle Scholar
• Sherr, C. J.. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984–2991
   PubMed Web of Science ®Google Scholar
• Shieh, S.-Y., Ikeda, M., Taya, Y., and Prives, C.. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325–334
   PubMed Web of Science ®Google Scholar
• Wu, X., Bayle, J. H., Olson, D., and Levine, A. J.. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126–1132
   PubMed Web of Science ®Google Scholar
• Yuan, Z.-M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y. Y., Lu, H., Kharbanda, S., Weichselbaum, R., and Kufe, D.. 1999. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399:814–817
   PubMed Web of Science ®Google Scholar
• Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G.Jr., Oren, M., Chen, J., and Lu, H.. 1999. MDM2 suppresses p73 function without promoting p73 degradation. Mol. Cell. Biol. 19:3257–3266
   PubMed Web of Science ®Google Scholar